ABL:BCR TK inhibitor
Treats CML (without cure)
APC mutation via truncation
Bcatenin accumulation
Auto Dom
0% risk of passing to offspring
Night sweats, leukocytosis, splenomegaly, fatigue
Philadelphia chromosome
cures CML
Auto Dom
RAS GAP/GTPase mutation
50% de novo mutation (germline mosaicism)
complete penetrance & variable expressivity
lisch nodules, neurofibromas, axillary/inguinal freckling
VegF up-regulates ___ resulting in apoptosis
treats von Hippel Lindau Syndrome
induces systemic toxicity
damage DNA; Normal cells arrest cell cycle & repair damage; Cancer cells: cell death after exposure from unrepaired DNA
repair pathway of ss DNA breaks by recombination
repairs ss DNA breaks
Inhibit Synthesis/ Function of DNA via Antimetabolite function
Topoisomerase Inhibitors to Inhibit Synthesis/ Function of DNA
Intercalating Agents that induce DNA damage
form complexes between guanine nucleotides mutation, DNA cross-linking, base excision & double strand breaks
Alkylation induces DNA damage via
Abnormal base-pairing with thymine mutation; excision of alkylated guanine residues (depurination); strand breakage
Inhibit enzymes of nucleoside triphosphate synthesis
Substitute for purines or pyrimidines
Bind topoisomerases & block ability to re-seal DNA breaks: cell death
Topoisomerase II Inhibitor
Binds, stabilizes microtubules, NO disassembly
Binds tubulin subunits, prevents polymerization
blocks proteosome activity --> active Bax & Bak
↑NFκB activity
prevents IκB degradation
survival (TF for IAPs, BCL-XL)
proliferation (TF for IL-4, IL-6)
monoclonal antibody inhibition of VEGF
monoclonal antibody inhibition of EGFR
monoclonal antibody inhibition of HER2
TK signalling inhibition of VEGF
TK signalling inhibition of EGFR
CDK inhibitor
ECM-derived Anti-Angiogenic Molecules
adrie
Quiz not verified by Sporcle
Show Comments